Aummune (אומיון)
Aummune (אומיון)
Claim
Aummune creates individualized therapeutics designed to specifically target each stage of a patient's disease. The company's platform addresses the need for safe, highly personalized, agile targeted therapies for cancer, antibiotic-resistant bacteria, and viruses. Ammune is currently a part of the aMoon Fund, an Israeli VC.Aummune creates individualized therapeutics designed to specifically target each stage of a patient' Show More
Alpha Score
Alpha Score
38.6
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0